UnitedHealthcare to offer coverage for Foundation Medicine CDx tests for multiple cancer types | LabPulse.com
Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
FDA-approved FoundationOne CDx assays until 22 March 2021. | Download Scientific Diagram
FoundationOne CDx – P170019/S014 | FDA
Foundation Medicine Unveils Strategy to Support Cancer CDx Filings with RWE from Clinico-Genomic Database | Precision Medicine Online
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin | PLOS ONE
Pfizer Taps Foundation Medicine for CDx Development
Multi-gene Testing (NGS) for PIK3CA Mutations
FoundationOne Liquid CDx
Foundation Medicine review - 7 facts you should know [DECEMBER 2021]
FoundationOne Liquid CDx
FoundationOne® CDx Cancer Genomic Profile Product Overview